Biotech News
Belhaven Biopharma Secures $11 Million in Funding for Nasdepi Clinical Program and FDA Preparation
Belhaven Biopharma has announced the launch of a new clinical study designed to evaluate the commercial dose of Nasdepi, an intranasal epinephrine product aimed at treating severe allergic reactions. The company has secured $11 million in funding through its fourth
23 January 2025